Trial intelligence / Profile preview

Isotretinoin, Biotinidase, and Depression in Acne

NCT06242288Phase 3Completed

Start
Jan 2024
Primary completion
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of isotretinoin in acne vulgaris. Started Jan 2024; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT06242288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06242288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call